HOW GOOD IS AN EECP HEART TREATMENT?
Enhanced external counterpulsation or EECP is a heart treatment designed for angina or chest pain. Despite its efficacy in dwindling angina manifestations among patients suffering from coronary heart disease, cardiologists have still not embraced this mechanism and are further researching its direction.
In addition, they continue to support more mainstream treatment plans. However, the significant breakthroughs are making a case for themselves, promising a future in the cardiology world. The best heart hospital in Bangalore assesses your condition and ascertains the ideal treatment plan for you.
EECP is conducted as a sequence of outpatient treatments. An individual is subjected to five sessions that last an hour and occur over seven weeks. The rationale is to stimulate enduring changes in a person’s circulatory system. The best heart hospital in Bangalore will study your case file thoroughly before adopting a plausible treatment for you.
HOW DOES IT WORK?
EECP is a method that uses long inflatable cuffs that are enveloped around a sufferer’s legs. They allow the patient to lie down flat while the cuffs are expanded and contracted in synchronization with every heartbeat. This mechanism is maneuvered by the computer, employing the patient’s electrocardiogram to induce inflation sooner in diastole (when the heart relieves and is brimming with blood) and relaxation just as systole (heart contraction) initiates.
The enlargement of the cuffs happens in a sequence; it starts from the bottom and makes its way to the top. Then, they attempt to milk the blood in the legs onto the heart.
IS IT EFFECTIVE?
Researchers have been emphasizing the potency of Enhanced external counterpulsation to treat angina or chest pain. There have been numerous studies conducted in this direction and have manifested positive results. The patients have exhibited enhanced manifestations of angina and exercise endurance in those suffering from coronary heart disease. However, it damages the heart’s vessels typically because of plaque build-up.
Certain studies believe that it can enhance the life quality among a heart patient parallel to the placebo treatment. The treatment’s efficacy lasts up to five years; however, it depends on personal cases. The rationale behind cardiologists staying dubious is the lack of testament that maintains these advantages.
The procedure has been found instrumental in stimulating the formation of collateral vessels in the coronary artery tree by inducing the discharge of nitric oxide and surplus augmentation constituents inside the coronary arteries.
Minimal data indicate that enhanced external counterpulsation acts as a type of subdued exercise that leads to the exact type of tenacious advantageous developments in the autonomic nervous system that manifest with regular workout routines.
CAN IT BE A DETRIMENT TO OUR HEALTH?
It is a painless treatment mode that is not fatal. Although the patients found the treatment method somewhat odd and uncomfortable, it will not lead to deadly effects. As a result, Medicare has supported EECP to treat heart patients who have tried all other treatment modes only to no avail.
Essentially this treatment is used when all other plans have failed people and serve as a last resort. However, the hallowed cardiology departments continue to disregard EECP because they find it unique and not in the best way. And, if the current treatment plans are working effectively for patients, cardiologists have a point in disapproving EECP.
Perhaps with more research and testimony, EECP will make its way into the treatment world.